Gene Surgery LLC
AntioncoRAN-M
Project description
AntioncoRAN-M is a Russian gene therapy drug for treating solid tumors, combining a cancer cell-killing gene and an immune activation gene. It has successfully completed Phase 1 clinical trials proving safety and shows promise against multiple cancer types, targeting a large oncology market with high unmet medical needs.
Аmount of required investment
On request
Estimated payback period
On request
Get project details
Topic:
Healthcare